RhApo2L/TRAIL Uses, Dosage, Side Effects and more
RhApo2L/TRAIL has been used in trials studying the treatment of Colorectal Cancer, Non-Hodgkin's Lymphoma, and Metastatic Colorectal Cancer.
| Attribute | Details |
|---|---|
| Trade Name | RhApo2L/TRAIL |
| Generic | Dulanermin |
| Dulanermin Other Names | Apo2L/TRAIL, Dulanermin, rhApo2L/TRAIL |
| Type | |
| Formula | C871H1329N243O260S4 |
| Weight | 19492.7851 Da |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
